Ads
related to: johnson & johnson- Latest news
See the latest news from J&J.
Company updates and more.
- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- The J&J Credo
Putting the needs of the
people we serve first.
- Discover J&J
Learn about our strength
in healthcare innovation.
- Latest news
Search results
J&J-backed Rapport Therapeutics raises $154 million in US IPO
Reuters via Yahoo News· 20 hours agoThe company said it plans to sell 8 million shares at $17 each, priced at the midpoint of its indicated price range of $16-$18 apiece. Rapport, backed by the venture capital arm of ...
Dallas Firm That Won $45M Talc Verdict Scored Again: Jury Hits J&J With $260M | Law.com
Law.com· 3 days agoThe Dallas plaintiffs’ firm that won a $45 million talc verdict against Johnson & Johnson scored a...
J&J must pay $260 million in latest talc trial, Oregon jury says
Reuters via Yahoo Finance· 4 days ago(Reuters) -Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma,...
7 Studies Likely to Reshape GI Care in the Years Ahead
Medscape· 15 hours agoDr David Johnson highlights the new studies from this year's Digestive Disease Week likely to impact...
3 Magnificent Dividend Stocks to Buy and Hold Forever
The Motley Fool via AOL· 6 days agoWhile there are many good alternatives for income investors, some stocks especially stand out. Here are three magnificent dividend stocks to buy and hold forever. 1. Johnson
Talc Plaintiffs Move to Quash Subpoenas as J&J Defends Attorney's Conduct | Law.com
Law.com· 7 days agoThe fight between Johnson & Johnson and plaintiffs firm Beasley Allen escalated this week with...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via AOL· 10 hours agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 4 days agoJohnson & Johnson today announced data from the Phase 3 PERSEUS study showing deepening of responses...
South Dakota Primary Election Results
New York Times· 15 hours agoGet live results and maps from the 2024 South Dakota primary elections.
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Forrest City Times-Herald· 4 days agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line ...
Ad
related to: johnson & johnson